Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecka Klintenberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Mass Spectrometry : JMS|February 12, 2005
Altered extracellular striatal in vivo biotransformation of the opioid neuropeptide dynorphin A(1-17) in the unilateral 6-OHDA rat model of Parkinson's diseaseRebecka Klintenberg, Per E Andrén
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2002
Tardive dyskinesia model in the common marmosetRebecka Klintenberg, Lars Gunne, Per E Andrén
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 13, 2005
Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicantsGary B Quistad, Rebecka Klintenberg, John E Casida
European Journal of Pharmacology|January 14, 2003
Motor effects of a dopamine stabilizer (GMC1111) in primate models of Parkinson and hemiparkinsonismRebecka Klintenberg, Joris Arts, Minke Jongsma, et al.
Toxicology and Applied Pharmacology|November 29, 2005
Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in miceGary B Quistad, Rebecka Klintenberg, Pierluigi Caboni, et al.
Toxicology and Applied Pharmacology|May 17, 2005
Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridatesGary B Quistad, Karl J Fisher, Sarah C Owen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 26, 2025
Response to the Letter to the Editor on "γ-Secretase modulation and plaque regression in Alzheimer's disease"Gunnar Nordvall, Ping Yan, Lotta Agholme, et al.
The Journal of Biological Chemistry|September 27, 2008
Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasomeArthur P Chou, Nigel Maidment, Rebecka Klintenberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 2025
γ-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein/presenilin-1 miceGunnar Nordvall, Ping Yan, Lotta Agholme, et al.
The Journal of Biological Chemistry|August 2, 2012
Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ productionJohanna Wanngren, Jan Ottervald, Santiago Parpal, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Mass Spectrometry : JMS|February 12, 2005
Altered extracellular striatal in vivo biotransformation of the opioid neuropeptide dynorphin A(1-17) in the unilateral 6-OHDA rat model of Parkinson's diseaseRebecka Klintenberg, Per E Andrén
Movement Disorders : Official Journal of the Movement Disorder Society|March 29, 2002
Tardive dyskinesia model in the common marmosetRebecka Klintenberg, Lars Gunne, Per E Andrén
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 13, 2005
Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicantsGary B Quistad, Rebecka Klintenberg, John E Casida
European Journal of Pharmacology|January 14, 2003
Motor effects of a dopamine stabilizer (GMC1111) in primate models of Parkinson and hemiparkinsonismRebecka Klintenberg, Joris Arts, Minke Jongsma, et al.
Toxicology and Applied Pharmacology|November 29, 2005
Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in miceGary B Quistad, Rebecka Klintenberg, Pierluigi Caboni, et al.
Toxicology and Applied Pharmacology|May 17, 2005
Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridatesGary B Quistad, Karl J Fisher, Sarah C Owen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 26, 2025
Response to the Letter to the Editor on "γ-Secretase modulation and plaque regression in Alzheimer's disease"Gunnar Nordvall, Ping Yan, Lotta Agholme, et al.
The Journal of Biological Chemistry|September 27, 2008
Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasomeArthur P Chou, Nigel Maidment, Rebecka Klintenberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 2025
γ-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein/presenilin-1 miceGunnar Nordvall, Ping Yan, Lotta Agholme, et al.
The Journal of Biological Chemistry|August 2, 2012
Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ productionJohanna Wanngren, Jan Ottervald, Santiago Parpal, et al.
Pageof 2